Skip to main content
. 2023 Nov 24;147(4):413–426. doi: 10.1159/000535228

Fig. 3.

Fig. 3.

OS, PFS, CIR, and TRM in patients with pulmonary MALT lymphoma who received systemic chemotherapy. Kaplan-Meier curve of OS (a) and PFS (b) and cumulative incidence of competing risk curve of CIR (c) and TRM (d).